Heterogeneous in vitro effects of doxorubicin on gene expression in primary human liposarcoma cultures

<p>Abstract</p> <p>Background</p> <p>Doxorubicin is considered one of the most potent established chemotherapeutics in the treatment of liposarcoma; however, the response rates usually below 30%, are still disappointing. This study was performed to identify gene expression changes in liposarcoma aft...

全面介紹

書目詳細資料

Principais autores:	Hans-Ulrich Steinau, Heinz-Herbert Homann, Jörg Hauser, Michael Chromik, Oliver Müller, Ludger Klein-Hitpass, Adrien Daigeler, Marcus Lehnhardt
格式:	Artigo
語言:	Inglês
出版:	BMC 2008-10-01
叢編:	BMC Cancer
在線閱讀:	http://www.biomedcentral.com/1471-2407/8/313
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!